Sinopharm Group To Center Antibiotic Production in Shanxi

Sinopharm Group will locate its antibiotic manufacturing center in Datong City, Shanxi province, at a facility it acquired as part of the purchase of Shandong Weiqida Pharma. Sinopharm is also reorganizing Aurobindo (Datong) Biopharma and will presumably move its antibiotic production into the Weiqida plant. More details... Stock Symbols: (HKEX: 01099)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.